BUGWORKS Research

About:

BUGWORKS is a drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR).

Website: http://bugworksresearch.com/

Top Investors: Global Brain Corporation, Lightrock, 3one4 Capital, UTEC - The University of Tokyo Edge Capital Partners, CARB-X

Description:

BUGWORKS is a drug discovery company that aims to discover novel pharmaceutical assets for combating Antimicrobial Resistance (AMR). The company was founded in 2014 and is based in Bangalore, India.

Total Funding Amount:

$45.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Bangalore, Karnataka, India

Founded Date:

2014-02-04

Contact Email:

info(AT)bugworksresearch.com

Founders:

Anand Anandkumar, Bala Subramanian

Number of Employees:

11-50

Last Funding Date:

2024-03-08

IPO Status:

Private

Industries: